mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.04 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.04 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |